Well differentiated thyroid carcinoma: Current treatment

Current Treatment Options in Oncology

Volumn 13, Issue 1, 2012, Pages 47-57

  Byrd, J Kenneth ^a   Yawn, Robert J ^a   Wilhoit, Christina S T ^a   Sora, Nicoleta D ^b   Meyers, Linda ^b   Fernandes, Jyotika ^b   Day, Terry ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Papillary thyroid cancer; Thyroglobulin; Thyroid cancer; Thyroidectomy

Indexed keywords

CALCIUM; DOXORUBICIN; IODINE 131; LEVOTHYROXINE; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROTROPIN; VITAMIN D;

ARTICLE; BONE DENSITY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; COST EFFECTIVENESS ANALYSIS; DIFFERENTIATED THYROID CANCER; ECHOGRAPHY; EDEMA; ERYTHEMA; FOLLOW UP; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; HYPOCALCEMIA; HYPOPARATHYROIDISM; ISTHMUSECTOMY; LARYNGEAL NERVE INJURY; LYMPH NODE METASTASIS; MINIMALLY INVASIVE VIDEO ASSISTED THYROIDECTOMY; MUCOSA INFLAMMATION; NECK DISSECTION; NECK EDEMA; PROGNOSIS; RADIATION THYROIDITIS; RADIOFREQUENCY ABLATION; RECURRENT LARYNGEAL NERVE INJURY; SIALOADENITIS; SIDE EFFECT; SKIN EXFOLIATION; SUBTOTAL THYROIDECTOMY; SUPERIOR LARYNGEAL NERVE INJURY; SURGICAL TECHNOLOGY; SURVIVAL RATE; THYROGLOBULIN BLOOD LEVEL; THYROID PAPILLARY CARCINOMA; THYROID SURGERY; THYROIDECTOMY; THYROIDITIS; TRANSAXILLARY ROBOTIC THYROIDECTOMY; TUMOR ABLATION; TUMOR BLEEDING; TUMOR VOLUME; VERTEBRA FRACTURE; XEROSTOMIA;

FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; NECK DISSECTION; PROGNOSIS; SURVIVAL RATE; THYROID NEOPLASMS; THYROIDECTOMY; THYROXINE; UNITED STATES;

EID: 84857659152     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-011-0173-1     Document Type: Article

References (46)

1. A Jemal, et al. 2009 Cancer Statistics 2009 CA Cancer J Clin 59 225 249 19474385 10.3322/caac.20006
2. JD Cramer, et al. 2010 Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registr Surgery 148 6 1147 1152 21134545 10.1016/j.surg.2010.10.016
3. E Kebebew J Weng J Bauer G Ranvier OH Clark Q-Y Duh G Shibru B Bastian A Griffin 2007 The Prevalence and Prognostic Value of BRAF Mutation in Thyroid Cancer Ann Surg 246 3 466 471 17717450 10.1097/SLA.0b013e318148563d This paper is an important addition to the evolving knowledge about the genetics of thyroid cancer.
4. LD Boudourakis, et al. 2009 Evolution of the surgeon-volume, patient-outcome relationship Ann Surg 250 1 159 165 19561457 10.1097/SLA.0b013e3181a77cb3
5. SA Hundahl, et al. 2000 Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study Cancer 89 1 202 217 10897019 10.1002/1097-0142(20000701)89:1<202::AID-CNCR27>3.0.CO;2-A 1:STN:280:DC%2BD3czlslSlsg%3D%3D (Pubitemid 30451292)
6. MB Flynn, et al. 1994 Local complications after surgical resection for thyroid carcinoma Am J Surg 168 5 404 407 7977960 10.1016/S0002-9610(05)80085-6 1:STN:280:DyaK2M%2FmvVKjsA%3D%3D (Pubitemid 24345683)
7. Morton, R.P., P. Whitfield, and S. Al-Ali, Anatomical and surgical considerations of the external branch of the superior laryngeal nerve: a systematic review. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 2006. 31(5): p. 368-74. (Pubitemid 44511156)
8. NA Pagedar JL Freeman 2009 Identification of the external branch of the superior laryngeal nerve during thyroidectomy Arch Otolaryngol Head Neck Surg 135 4 360 362 19380357 10.1001/archoto.2009.9
9. S Sabour E Manders DL Steward 2009 The role of rapid PACU parathyroid hormone in reducing post-thyroidectomy hypocalcemia Otolaryngol Head Neck Surg: Off J Am Acad of Otolaryngol Head Neck Surg 141 6 727 729 10.1016/j.otohns.2009. 08.026
10. KY Bilimoria, et al. 2007 Extent of surgery affects survival for papillary thyroid cancer Ann Surg 246 3 375 381 17717441 10.1097/SLA. 0b013e31814697d9
11. J Jonklaas, et al. 2006 Outcomes of patients with differentiated thyroid carcinoma following initial therapy Thyroid: Off J Am Thyroid Assoc 16 12 1229 1242 10.1089/thy.2006.16.1229 (Pubitemid 46080167)
12. E Baudin, et al. 1998 Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience Cancer 83 3 553 559 9690549 10.1002/(SICI)1097-0142(19980801)83:3<553::AID-CNCR25>3.0.CO;2-U 1:STN:280:DyaK1czlt1ymuw%3D%3D (Pubitemid 28354512)
13. Thyroid Carcinoma. NCCN Clinical Practice Guidelines in Oncology 2011 [cited 2011; 3.2011]Available from: www.nccn.org.
14. EL Mazzaferri SM Jhiang 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer Am J Med 97 5 418 428 7977430 10.1016/0002-9343(94)90321-2 1:STN:280:DyaK2M%2FmvVSgtA%3D%3D (Pubitemid 24345593)
15. SE Carty, et al. 2009 Consensus statement on the terminology and classification of central neck dissection for thyroid cancer Thyroid: Off J Am Thyroid Assoc 19 11 1153 1158 10.1089/thy.2009.0159
16. Shaha, A.R., Controversies about the central compartment in thyroid cancer. Editorial regarding the article "Clinical impact of cervical lymph node involvement and central neck dissection in patients with papillary thyroid carcinoma: a retrospective analysis of 368 cases" by Alexandre Bozec et al. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies, 2011. 268(8): p. 1097-9.
17. T Zetoune, et al. 2010 Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis Ann Surg Oncol 17 12 3287 3293 20596784 10.1245/s10434-010-1137-6
18. T Ecker, et al. 2010 Hemostasis in thyroid surgery: harmonic scalpel versus other techniques - a meta-analysis Otolaryngol Head Neck Surg: Off J Am Acad Otolaryngol Head Neck Surg 143 1 17 25 10.1016/j.otohns.2010.03.018
19. TS Higgins, et al. 2011 Recurrent laryngeal nerve monitoring versus identification alone on post-thyroidectomy true vocal fold palsy: a meta-analysis Laryngoscope 121 5 1009 1017 21520117 10.1002/lary.21578
20. Samraj, K. and K.S. Gurusamy, Wound drains following thyroid surgery. Cochrane database of systematic reviews, 2007(4): p. CD006099.
21. P Miccoli, et al. 1999 Minimally invasive surgery for thyroid small nodules: Preliminary report J Endocrinol Invest 22 849 851 10710272 1:STN:280:DC%2BD3c7ntlGjtA%3D%3D (Pubitemid 30083177)
22. P Miccoli, et al. 2006 Video-assisted thyroidectomy: indications and results Langenbecks Arch Surg 391 68 71 16572329 10.1007/s00423-006-0027-7
23. G Sgourakis, et al. 2008 Comparison between minimally invasive video-assisted thyroidectomy and conventional thyroidectomy: is there any evidence-based information? Thyroid: Off J Am Thyroid Assoc 18 7 721 727 10.1089/thy.2008.0028 (Pubitemid 352009935)
24. JK Byrd, et al. 2010 Minimally invasive video-assisted thyroidectomy versus conventional thyroidectomy: a cost-effective analysis Otolaryngol Head Neck Surg: Off J Am Acad Otolaryngol Head Neck Surg 143 6 789 794 10.1016/j.otohns.2010.08.002
25. RB Kuppersmith FC Holsinger 2011 Robotic thyroid surgery: an initial experience with North American patients Laryngoscope 121 3 521 526 21344427 10.1002/lary.21347
26. Tae, K., et al., Early surgical outcomes of robotic thyroidectomy by a gasless unilateral axillo-breast or axillary approach for papillary thyroid carcinoma: 2 years' experience. Head & Neck, 2011.
27. DJ Terris MC Singer MW Seybt 2011 Robotic facelift thyroidectomy: patient selection and technical considerations Surg Laparosc Endosc Percutan Tech 21 4 237 242 21857471 10.1097/SLE.0b013e3182266dd6
28. T Wilhelm A Metzig 2011 Endoscopic minimally invasive thyroidectomy (eMIT): a prospective proof-of-concept study in humans World J Surg 35 3 543 551 21088839 10.1007/s00268-010-0846-0
29. LJ DeGroot, et al. 1990 Natural history, treatment, and course of papillary thyroid carcinoma J Clin Endocrinol Metab 71 2 414 424 2380337 10.1210/jcem-71-2-414 1:STN:280:DyaK3czjvVeisQ%3D%3D
30. AM Sawka, et al. 2004 Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer J Clin Endocrinol Metab 89 8 3668 3676 15292285 10.1210/jc.2003-031167 1:CAS:528:DC%2BD2cXmslKmsbc%3D (Pubitemid 39089119)
31. DS Cooper GM Doherty BR Haugen RT Kloos SL Lee SJ Mandel EL Mazzaferri B McIver F Pacini M Schlumberger SI Sherman DL Steward RM Tuttle 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid 19 1167 1214 10.1089/thy.2009.0110 19860577 10.1089/thy.2009.0110 The revised version of the American Thyroid Association management guidelines for patients with differentiated thyroid cancer provides an important review of current data on therapeutic modalities and offers improved clinical strategies for the optimal management of this thyroid pathology.
32. A Jukkola, et al. 2004 Prognostic Factors in Differentiated Thyroid Carcinomas and Their Implications for Current Staging Classifications Endocr Relat Cancer 11 571 579 15369456 10.1677/erc.1.00826 (Pubitemid 39331285)
33. D Meier, et al. 2002 Procedure guideline for Therapy of Thyroid Disease with 131Iodine J Nucl Med 43 6 856 861 12050333 1:CAS:528:DC%2BD38XltFOnsrw%3D (Pubitemid 34663310)
34. RJ Robbins, et al. 2002 A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation J Nucl Med: Off Publ, Soc Nucl Med 43 11 1482 1488 1:CAS:528: DC%2BD38XptV2mt7k%3D (Pubitemid 35285874)
35. H Tala, et al. 2011 Five-Year Survival is Similar in Thyroid Cancer Patients with Distant Metastases Prepared for Radioactive Iodine Therapy with either Thyroid Hormone Withdrawal or Recombinant Human TSH J Clin Endocrinol 96 7 2105 2111 10.1210/jc.2011-0305 1:CAS:528:DC%2BC3MXptlSrt74%3D
36. JC Sisson, et al. 2011 Radiation safety in the treatment of patients with thyroid diseases by radioiodine (1)(3)(1)i: practice recommendations of the american thyroid association Thyroid: Off J Am Thyroid Assoc 21 4 335 346 10.1089/thy.2010.0403
37. SL Lee 2010 Complications of radioactive iodine treatment of thyroid carcinoma J Natl Compr Cancer Netw: JNCCN 8 11 1277 1286
38. Perez CA, Santos ES, Arango BA, Raez LE, Cohen EW. Novel molecular targeted therapies for refractory thyroid cancer. Head Neck Epub ahead of print doi: 10.1002/hed.21755 2011.
39. Monchik, et al. 2006 Radiofrequency Ablation and Percutaneous Ethanol Injection Treatment for Recurrent Local and Distant Well-Differentiated Thyroid Carcinoma Ann Surg 244 2 296 304 16858194 10.1097/01.sla.0000217685.85467.2d (Pubitemid 44305546)
40. B Biondi S Filetti M Schlumberger 2005 Thyroid-hormone therapy and thyroid cancer: a reassessment Nat Clin Pract Endocrinol Metab 1 32 40 ncpendmet0020 [pii]10.1038/ncpendmet0020 16929364 10.1038/ncpendmet0020 1:CAS:528:DC%2BD28Xis1Sisbs%3D
41. CT Sawin A Geller PA Wolf AJ Belanger E Baker P Bacharach PW Wilson EJ Benjamin RB D'Agostino 1994 Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons N Engl J Med 331 1249 1252 10.1056/NEJM199411103311901 7935681 10.1056/NEJM199411103311901 1:STN:280:DyaK2M%2FitFGqsg%3D%3D (Pubitemid 24333188)
42. S Fazio B Biondi C Carella D Sabatini A Cittadini N Panza G Lombardi L Sacca 1995 Diastolic dysfunction in patients on thyroid-stimulating hormone suppressive therapy with levothyroxine: beneficial effect of beta-blockade J Clin Endocrinol Metab 80 2222 2226 7608283 10.1210/jc.80.7.2222 1:CAS:528:DyaK2MXmvVyqurY%3D
43. DC Bauer B Ettinger MC Nevitt KL Stone 2001 Risk for fracture in women with low serum levels of thyroid-stimulating hormone Ann Intern Med 134 561 568 12803168 1:CAS:528:DC%2BD3MXivVaju7c%3D (Pubitemid 32245317)
44. RT Kloos 2005 Papillary thyroid cancer: medical management and follow-up Curr Treat Options Oncol 6 323 338 15967085 10.1007/s11864-005-0036-8 (Pubitemid 41223386)
45. RM Tuttle R Leboeuf AR Shaha 2008 Medical management of thyroid cancer: a risk adapted approach J Surg Oncol 97 712 716 10.1002/jso.21010 18493922 10.1002/jso.21010 We have found that the described risk adapted approach in this paper allows optimal tailoring of the aggressiveness of therapy and follow up for individual patients. (Pubitemid 351812974)
46. EL Mazzaferri RJ Robbins CA Spencer LE Braverman F Pacini L Wartofsky BR Haugen SI Sherman DS Cooper GD Braunstein S Lee TF Davies BM Arafah PW Ladenson A Pinchera 2003 A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma J Clin Endocrinol Metab 88 1433 1441 12679418 10.1210/jc.2002-021702 1:CAS:528:DC%2BD3sXjtFCmu7k%3D (Pubitemid 36623351)